<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>18</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2017</Year>
					<Month>02</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Hyperuricemia at The Time Of Diagnosis is a Factor for Poor Prognosis in Patients With Stage II and III Colorectal Cancer (Uric Acid and Colorectal Cancer)</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>485</FirstPage>
			<LastPage>490</LastPage>
			<ELocationID EIdType="pii">44113</ELocationID>
			
<ELocationID EIdType="doi">10.22034/APJCP.2017.18.2.485</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Ahmet Ozan </FirstName>
					<LastName>Cetin</LastName>
<Affiliation>Mugla Sitki Kocman University Faculty of Medicine, Department of Internal Medicine, Mugla</Affiliation>

</Author>
<Author>
					<FirstName>Muhyettin </FirstName>
					<LastName>Omar</LastName>
<Affiliation>Mugla Sitki Kocman University Faculty of Medicine, Department of Internal Medicine, Mugla</Affiliation>

</Author>
<Author>
					<FirstName>Serkan </FirstName>
					<LastName>Calp</LastName>
<Affiliation>Mugla Sitki Kocman University Faculty of Medicine, Department of Internal Medicine, Mugla</Affiliation>

</Author>
<Author>
					<FirstName>Hasan </FirstName>
					<LastName>Tunca</LastName>
<Affiliation>Mugla Sitki Kocman University Faculty of Medicine, Department of Internal Medicine, Mugla</Affiliation>

</Author>
<Author>
					<FirstName>Nevin </FirstName>
					<LastName>Yilmaz</LastName>
<Affiliation>Mugla Sitki Kocman University Faculty of Medicine, Department of Internal Medicine, Division of Gastroentero-hepatology, Mugla</Affiliation>

</Author>
<Author>
					<FirstName>Burak </FirstName>
					<LastName>Ozseker</LastName>
<Affiliation>Mugla Sitki Kocman University Faculty of Medicine, Department of Internal Medicine, Division of Gastroentero-hepatology, Mugla</Affiliation>

</Author>
<Author>
					<FirstName>Ozgur </FirstName>
					<LastName>Tanriverdi</LastName>
<Affiliation>Mugla Sitki Kocman University Faculty of Medicine, Department of Oncology</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2016</Year>
					<Month>12</Month>
					<Day>13</Day>
				</PubDate>
			</History>
		<Abstract> &lt;br /&gt; &lt;strong&gt;&lt;span style=&quot;font-size: small;&quot;&gt;Purpose: &lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-family: Times New Roman,Times New Roman; font-size: small;&quot;&gt;&lt;span style=&quot;font-family: Times New Roman,Times New Roman; font-size: small;&quot;&gt;In this pilot study we investigated whether serum levels of uric acid, the final breakdown product of purine metabolism, might influence cancer-related events in stage II and III colorectal cancer patients. &lt;/span&gt;&lt;/span&gt;&lt;strong&gt;&lt;span style=&quot;font-size: small;&quot;&gt;Material and methods: &lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-family: Times New Roman,Times New Roman; font-size: small;&quot;&gt;&lt;span style=&quot;font-family: Times New Roman,Times New Roman; font-size: small;&quot;&gt;In this cross-sectional retrospective study, a total of 150 stage II and III colorectal adenocarcinoma patients with no exclusion criteria were included. Serum uric acid levels of the patients measured at diagnosis and demographic, &lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-family: Times New Roman,Times New Roman; font-size: small;&quot;&gt;&lt;span style=&quot;font-family: Times New Roman,Times New Roman; font-size: small;&quot;&gt;clinical, laboratory analyses were performed and histologically features recorded. Patients were stratified into quartiles &lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-family: Times New Roman,Times New Roman; font-size: small;&quot;&gt;&lt;span style=&quot;font-family: Times New Roman,Times New Roman; font-size: small;&quot;&gt;according to serum uric acid level with different cut-off values. &lt;/span&gt;&lt;/span&gt;&lt;strong&gt;&lt;span style=&quot;font-size: small;&quot;&gt;Results: &lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-family: Times New Roman,Times New Roman; font-size: small;&quot;&gt;&lt;span style=&quot;font-family: Times New Roman,Times New Roman; font-size: small;&quot;&gt;The mean serum uric acid level of all patients was determined o be 6.97±2.87 md/dL (range, 3.1-12.4). Median follow-up time was 98 (range 9-98) months and the proportion of patients who did not relapse was 22%. It was determined that majority of the patients who had serum uric acid levels over 8.37 mg/dL had stage IIIB lesions, were smokers, were among those who lost weight, with metastasis &lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-family: Times New Roman,Times New Roman; font-size: small;&quot;&gt;&lt;span style=&quot;font-family: Times New Roman,Times New Roman; font-size: small;&quot;&gt;to the liver and with significantly leukocyte and platelet counts. &lt;/span&gt;&lt;/span&gt;&lt;strong&gt;&lt;span style=&quot;font-size: small;&quot;&gt;Conclusions: &lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-family: Times New Roman,Times New Roman; font-size: small;&quot;&gt;&lt;span style=&quot;font-family: Times New Roman,Times New Roman; font-size: small;&quot;&gt;Serum uric acid levels measured at the time of diagnosis may be associated with cancer-related events so we can conclude a prognostic value of increase in colorectal cancer patients. &lt;/span&gt;&lt;/span&gt;</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Uric Acid</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">colorectal cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Prognosis</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_44113_16a1e1576f441b4322a5de89d161f8c0.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
